GSK plc (FRA:GS71)

Market Cap	69.98B
Revenue (ttm)	36.90B
Net Income (ttm)	3.99B
Shares Out	n/a
EPS (ttm)	0.96
PE Ratio	17.52
Forward PE	8.71
Dividend	0.75 (4.38%)
Ex-Dividend Date	Aug 14, 2025

Volume	923,191
Average Volume	558
Open	17.57
Previous Close	17.43
Day's Range	17.46 - 18.33
52-Week Range	14.68 - 18.86
Beta	n/a
RSI	59.25
Earnings Date	Oct 29, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 68,629
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GS71

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP